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ABSTRACT 
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3 figures 
November 1992 
The use of gene technology has enabled the plant breeder to introduce foreign genes trom 
evolutionary far related species into existing selection lines. These lines can thereby be improved with 
respect to a variety of (quality) traits. 
The rapid progress of these scientific developments has urged regulatory authorities to consider the 
necessity of additional reguiatien tor novel food products derived trom these genetically modified 
plants. A number of advisory reports has already been publishad on the issue. So far, the FDA (USA) 
is the only regulatory institution that has publishad a statement of policy. 
In this report risk evaluation strategies as proposed by national and international bodies, either issued 
or under development, are reviewed and suggestions are made tor further impravement of risk 
evaluation procedures tor genetically modified complex products. 
Keywords: food safety regulat ion, genetic modification, plant breeding 
PREFACE 
New technologies entail new questions. The greater the power of the new technology the more 
numerous the questions will be. Recombinant-DNA techniques are nat an exception to this rule. In 
theory, the number of possible applications of these new techniques is almast unlimited as is the 
number of problems to be foreseen when the techniques are applied. In practice, the number of 
applications is rather limited (tor the time being) and it is seems to be possible (in the near future) to 
perfarm a reliable risk assessment of the new products obtained in this way. Such a risk assessment 
does nat have to yield to risk assessment procedures, if available, tor new products obtained by 
means of classica! breeding. 
In this report an inventarisation is made of possible applications of genetic modification in agriculture 
and (proposed) strategies tor adequate food safety assessment of these products. Also a number 
of bottle-necks tor optimal risk assessment procedures is discussed. 
This report is written within the framework of the RIKILT-DLO project 'Risk analysis on navel foods tor 
the consumer' as part of the 'Ecological, social and ethical aspects of biotechnology' program 
financed by the Department of Science and Technology of the Dutch Ministry of Agriculture, Nature 
GanseNation and Fisheries. 
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SUMMARY 
Recent developments in gene technology have enabled plant breeders to establish genetic 
combinations that could not be obtained by means of classica! breeding procedures. Thereby it has 
proved feasible to imprave a number of (qualitative) characteristics in saveral plant species. Examples 
of such improved characteristics by means of genetic modification are disease resistance, insect 
resistance, trost resistance, prolonged shelf-life and starage quality, nutritional value and sensoric 
characteristics. Other traits that can be modified in this way are a.o. herbicide resistance and male 
sterility. 
Because of these developments in plant breeding national and international regulatory bodies have 
considered the question as to how adequate existing regulation is with respect to the food safety 
aspects of novel foods derived trom genetically modified organisms. This has resulted in a number 
of advisory reports proposing different strategies tor risk assessment. Important international reports 
in this respect are the IFBC (International Food Biotechnology Council) and FAO/WHO reports and 
the EC and OECD (draft) reports. Proposals tor national regulation have been published in Great 
Britain and the Netherlands. In addition a Skandinavian advisory organ has publishad guidelines. So 
far only the United States has tormulated official guidelines. In this report the different strategies to 
assess the food safety of genetically modified agricultural products are evaluated and suggestions are 
made tor further impravement of risk evaluation procedures tor genetically modified complex products. 
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1 APPLICATIONS OF GENETIC MODIFICATION 
1.1 Introduetion 
In a remarkably short space of time, recombinant-DNA techniques have found a wide range of 
applications within the plant breeding sector. The most frequently used application is the detection 
of specific DNA sequences that code tor or correlate with a desirabie production trait. In the first case 
it is the gene itself that causes the trait, while in the second a bordering sequence or a functionally 
related gene is involved. Within the framework of several research networks, gene maps of important 
lood crops, such as tomato and potato, are currently being made in various places. Because the 
presence of desirabie traits can now be determined at any stage of development, insight into genetic 
structure at the DNA level can be helptul to plant breeders in accelerating selection procedures. 
Whereas in the past one needed fully grown plants in order to be able to test for traits such as 
disease resistance or yield, it is now possible, at least if the specific trait is DNA-characterised, to 
perfarm a simple DNA test during the germination phase. 
However, the most remarkable application of recombinant-DNA techniques in the plant breeding 
industry is the genetic modification of food plants. Genetic modification is possible using genes that 
are already naturally present in the plant (cisgenesis) and which are only artificially amplified. However, 
most applications of genetic modification relate to the introduetion of foreign genes of vegetable, 
bacterial, animal or even human origin (transgenesis). The DNA code is universa! and therefore, in 
principle, exchangeable between allliving organisms. Dialects, however, do occur with the code and 
for the sake of increased expression levels it is sametimes desirabie to 'translate' the DNA trom the 
donor organism to the code of the acceptor organism befare introducing the DNA segment into the 
genome of the acceptor. 
Several different transformation systems tor establishing genetic modification are currently available 
[lindsey et al., 1989]. The most frequently used, and so lar the most efficient, is the system that 
makes use of the bacterium Agrobacterium tumefaciens. This bacterium contains a plasmld with a 
transposable element which, when it infects vegetable material, can be transferred to the genetic 
material of the plant. By substituting part of this transposon by a gene coding tor a desirabie trait it 
has proved possible to transfer a desirabie trait into the DNA of plant cells. Apart trom the 
Agrobacterium tumefaciens system, other systems have been developed, such as electroporation, 
micro-injection and a system that uses micro-projectiles to genetically modify plant cells. However, 
these alternative systems, at least in dicotyledons have nat proved to be as efficient as the 
Agrobacterium tumefaciens system. 
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Other important techniques that are applied to establish genetic modification (but where there is no 
direct modification) are somaclonal variation and protoplast fusion. Somaclonal variation is a 
phenomenon related to cell culture procedures. Genetic variation can occur as a result of 
spontaneous mutations at already existing loci, but the possibility that new genes may arise in this 
way cannot be excluded [Cocking, 1990). However, in a number of species it has proved to be rather 
ditticuit to grow new plants trom the cultured cells. Using protoplast fusion, transgenie plants that 
combine characteristics of strains or species that cannot be crossed in the classical way can be 
obtained. Protoplast fusion can be established under the influence of high voltage or by means of 
polyethylene glycol (PEG). The fusion results in a heterokaryen that can subsequently grow into a 
plant. Fora long time now, protoplast fusion has been the only available methad to genetically modify 
monocotyledonous species, such as rye or rice (Van der Maas et al., 1990; Hensgens et al., 1990). 
The extremely low efficiency of heterokarya to grow into plants has been a major problem in plant 
breeding tor many years [Cocking, 1990; Lazzeri et al. , 1990). lt is not only possible to introduce 
toreign genetic material into the nucleus but, indirectly, it also seems possible to produce transgenie 
mitochondria by means of tRNA of nuclear sequences [Smal! et al., 1992). This technique, however, 
has not yet been fully developed and it is still not clear whether the relatively large DNA fragments, 
necessary to accomplish an effect, can be introduced in this way. 
The list of transformabie food plants is growing steadily. Although a considerable number of genetic 
modification experiments in plants are still being performed tor fundamental research purposes, the 
number of experiments directed to imprave certain production characteristics of economically 
important food plant variaties is increasing. So far these improvements have been limited to those 
characteristics coded tor by just one characterised and localised gene. Therefore, the number of 
agronomically important traits that can be improved by genetic modification is still rather smal!, 
because the majority of interesting traits are based on a combined action of several genes at the 
same time. 
1.2 Disease resistance 
Virus resistance is the trait that is most aften introduced by genetic modification. Virus resistance has 
been obtained in this way tor example in tobacco, tomato, potato, melon, sugar beet, soy beans, 
alfalfa, artichokes and rice. Resistance to various viruses, such as the alfalfa mosaic virus, cucumber 
mosaic virus, potato viruses X (PVX) and Y (PVY) and potato leaf roll virus can be achieved [Nelson 
et al., 1990; Fraley, 1992). Furthermore, experiments to introduce virus resistance in cassava are in 
progress [Persley, 1990). To establish resistance, several genes coding for viral proteins have been 
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introduced into the genome of these species. This strategy has proved successtul in saveral cases, 
although the mechanism that leads to resistance is not yet fully understood. 
Other methods of obtaining virus resistance have been developed, incorporating other viral sequences 
nat coding tor coat proteins. For example, resistance to the tobacco mosaic virus has been achieved 
by incorporating part of the replicase gene of the virus [Fraley, 1992). However, recent experiments 
have shown that resistance obtained in this way can be nullified when the introduced DNA fragment 
recombines with a detective virus that is lacking in the transgenie sequences. The consequences tor 
the biosafety of plant variaties which have viral sequences added to their genome are nat clear (Gal 
et al., 1992; Allison et al. , 1990; Creamer et al., 1990). Other strategies possibly leading to virus 
resistance are, tor example, the introduetion of antisense viral transcripts, expression of antiviral 
antibodies or expression of interferon (Gadani et al., 1990). Sa far these methods have not resulted 
in effective resistance. A certain dagree of resistance to the fungi Alternaria longipes and Rhizoctonia 
spp. has been achieved by incorporating the bacterial chitinase gene into tomato, potato, lettuce and 
sugar beet (Fraley, 1992; Jones, 1992). In addition, experiments are being done to obtain resistance 
to bacterial diseases by introducing saveral antibacterial agents derived trom insacts (e.g. sarcotoxins, 
apidaecins, cecropins), vertebratas (magainins) ar plants (thionins) [Fiorack et al., 1990). Transgenie 
tobacco plants containing the gene tor acetyltransferase have been shown to be resistant to wild fire, 
caused by Pseudomonas syringae. 
1.3 Insect resistance 
Several methods have been developed to make commercial plant variaties resistant to a series of 
voracious insects. The one most aften applied involves the introduetion of a gene that codes tor a 
crystalline protein of the bacterium Bacillus thuringiensis. Researchers trom Plant Genetic Systems 
(Belgium) were the first to introduce insect resistance in tobacco plants by incorporating the St-gene. 
This protein exerts its insecticidal action specifically with respect to the larvae of saveral harmful 
insects. Many B. thuringiensis strains have been characterised, all of which show specific taxicity to 
certain insect families. Most strains are active against the larvae of specific butterfly species. Others 
are also active against Diptera ar Colsoptera species. For many strains, the specific activity still needs 
to be determined [Goré et al., 1986). The gene that codes tor the active toxin has been incorporated 
in tomato, potato, walnut, rice, corn and cotton, etc. [Harlander, 1990; Perlak et al., 1990) and has 
been shown to be rather effective against the varacity of saveral larvae. Furthermore, it has been 
found that effectivity increases with improved expression as a result of 'translation' of the bacterial 
DNA into a code that is more easily recognised in plant cells [Perlak et al., 1990). 
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Another way of introducing insect resistance in plants is to use proteinase inhibitors. These 
compounds occur naturally in Leguminosae and cereals and are thus already present in substantial 
amounts in the human diet. The inhibitor that has hitherto been used most often in genetic 
modification experiments is the cowpea trypsin inhibitor [Hilder et al., 1990]. In transgenie plants 
expression of these proteinase inhibitors needs to be relatively high in order to exert the des i red effect. 
The tact that inhibitors cannot exert their insect resistant effect in the absence of other taxie factors 
can, therefore, not be excluded. Proteinase inhibitors have been introduced tor example in tobacco 
and potato. In these species insect resistance can also be achieved by introducing leetin genes 
(haemagglutinins) [Edwards et al., 1991]. Lectins are abundant in nature, especially in the seeds of 
Leguminosae. They are capable of binding carbohydrates specifically, but the precise mechanism of 
insect resistance still needs to be clarified. 
1.4 Frost resistance 
Experiments are currently being performed to determine the effects of treezing and thawing on the 
composition and taste of transgenie tomatoes into which a gene has been introduced that codes tor 
an anti-treezing protein. The protein is derived trom the winter flounder which, with the aid of this 
protein, protects itself against treezing in the Arctic seas. lf the experiments are successful the next 
step will be to make strawberries frost-resistant in a similar way [Jones, 1992]. Some of the first field 
experiments were concerned with genetically modified bacteria in which the 'ice' gene was lacking. 
This gene codes tor a protein which catalyses the formation of ice crystals under specific 
environmental conditions. lt was shown that when plants are sprayed with ice-bacteria a certain 
degree of trost resistance can be achieved. 
1.5 Herbicide resistance 
Resistance to several herbicides has been accomplished. This development can in principle result in 
the more widespread application of more effective or biologically degradable herbicides. Another way 
in which herbicide resistance genes can be applied is as marker genes in transformation experiments. 
This application is particularly important tor research purposes. 
Herbicide resistance occurs naturally in several plant species. lt has been shown that this resistance 
is otten caused by a single dominant mutation. Herbicide resistance can be achieved by modifying 
the expression level and sensitivity of the target enzyme of the herbicide or by introducing a gene that 
causes detoxification of the herbicide into the plant genome [Oxtoby et al., 1990]. The first methad 
is mainly applied with respect to herbicides interacting with plant photosynthesis, tor example triazins, 
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or amino acid synthesis, tor example glyphosate (Aoundup), phosphinotricin (Basta), sulphonylureas 
and imidazolinones. Triazin resistance (atrazin) has been achieved in tobacco, and experiments are 
currently being performed on Brassica and Solanum strains. Experiments are also in progress to 
achieve resistance to the photosynthesis inhibitor Bromoxynil by introducing the bacterial bxn gene 
into tobacco and tomato plants. The bxn gene that codes tor nitrilase is capable of detoxifying 
Bromoxynil. In a similar way, attempts are being made to introduce phosphinotricin resistance into 
tobacco, potato and tomato by means of the bacterial bar gene that codes tor an acetyltransferase. 
Many herbicides are rapidly degraded by soil bacteria. These bacteria are therefore a rich souree of 
herbicide resistance genes. Glyphosate tolerance, using target enzyme modification, has been 
achieved in tobacco, tomato and Petunia. Phosphinotricin, sulphonylurea and imidazolinone resistance 
has been accomplished in a similar way in tobacco, soy beans and maize. Finally, experiments are 
currently being done using tobacco plants to introduce the bacterial tfdA gene in order to obtain 
resistance to the herbicide 2,4-D, which is a growth inhibitor. The target enzyme of 2,4-D has not yet 
been identified [Oxtoby et al., 1990; Llewellyn et al., 1990; Fraley, 1992]. 
1.6 Shelf-life and storage quality 
lmproved storage quality and prolonged shelf-life have been achieved by the inactivation of specific 
genes. This inactivation is brought about by introducing antisense sequences. In tomato, introducing 
the antisense sequence of the gene coding tor the polygalacturonase enzyme has resulted in the 
al most complete disappearance of this specific enzyme in ripening tomatoes [Lindsey, 1991; Grierson 
et al., 1990). In an alternative strategy to prolong shelf-life and improve the storage quality of 
tomatoes, the antisense sequence of 1-aminocyclopropane-1-carboxylate (ACC) or of ACC-oxidase 
(both enzymes being involved in ethylene synthesis) has been introduced [Lindsey, 1991; Fraley, 
1992; Jones, 1992). Although it is generally assumed that effective translation is inhibited by 
hybridisation of the sense and antisense RNA fragments, the exact mechanism behind the effectivity 
of the antisense sequences is not yet fully understood [Holden, 1990). Modification of flower colour 
in Petunia is based on inactivation of the chalconsynthase enzyme involved in flavonoid synthesis 
[Lindsey, 1991). In this case, no antisense genes are involved but inactivation is caused by an 
unknown interaction between several chalconsynthase genes present. Another technique being 
developed and which should lead to the inactivation of specific genes, makes use of genetically 
modified ribozymes. Ribozymes are RNA particles with extremely specific endoribonuclease activity 
[Holden, 1990). Specific ribozymes can be developed tor specific mRNA sequences, thereby inhibiting 
the translation of these sequences into protein. 
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1. 7 Male sterility 
Male sterility has been achieved in rapeseed, tobacco, lettuce, chicory, cotton, tomato and maize by 
introducing a specific promotor joined to a fungus-derived RNAse. The promotor is tissue (tapetum 
celllayer in the anthers) and development stage specific [Rochaix, 1992].1ntroducing the gene coding 
for this RNAse inhibits pollen formation which results in sterile male plants, which can subsequently 
be used in classica! breeding strategies to obtain hybrid plants with the desired characteristics. 
Fertility of these plants can, if necessary, be restored by introducing a specific RNAse inhibitor in 
plants of the same variety. Crossing these two transgenie strains will result in some fertile plants. 
1.8 Nutritional composition 
Modifications in the metabolism of a plant can lead to improved nutritional composition. One example 
of this is the modification of the metabolism of rapeseed resulting in modilied fatty acid chains with 
an increased nutritional value [Amer. Medic. Ass., 1991 ]. Nutritional characteristics can also be 
improved by introducing nonsense proteins with a favourable amino acid composition, by expression 
of specific genes [Lindsey et al., 1989] or by eliminating harmful metabolites in specific plant variaties. 
Research to imprave the amino acid production of potatoes and the amino acid composition of 
cassava by introducing synthetic genes is currently being carried out [Persley, 1990]. Furthermore, 
it has been shown that it is possible to increase starch production in potatoes by twenty to forty per 
cent by expressing the bacterial ADP-glucose-pyrophosphorylase gene under the control of a tissue-
specific patatin promotor [Fraley, 1992; Rochaix, 1992]. A higher starch level will reduce the casts of 
processing and lead to decreased fat absorption during frying. lncreased sucrose and reduced starch 
levels have been obtained by introducing the sucrose phosphate synthase gene. lncreasing the 
expression of certain genes can be achieved by replacing the traditional promotor by one with a 
higher activity ar by one that causes prolonged expression of the gene in the development of the 
plant or in organs other than the traditional ones. However, only very tew tissue or developmental 
stage specific promotors have yet been identified. Besides modifications in metabolism tor nutritional 
purposes other modifications in metabolism have been accomplished that serve industrial applications 
(agrification). 
1.9 Sensory characteristics 
Experiments to imprave the sensory characteristics of plant produels are performed with genes coding 
tor, amongst others, thaumatin and monellin. These proteins are the sweetest compounds known at 
present. They are derived trom the plants Thaumatococcus daniellii and Dioscoreophyllum cumminsii, 
respectively. Thaumatin genes have been expressed in potato [Jones, 1992]. Monellin has been 
introduced into tomalo and lettuce [Penarrubia et al., 1992]. lt is expected that these natura! non-
sugar sweeteners will find wider application in the near tuture. 
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2 GUIDELINES 
2.1 Introduetion 
We have seen trom the previous chapter that there are many ways of modifying speeltic 
characteristics of organisms by means of genetic modification. Modification can imply the introduetion 
of a gene (product), but also modified expression ar inactivation. These farms of genetic 
recombination are now applied quite extensively in micro-organisms and plants and to a somewhat 
lesser extent in animals. Examples of applications in the food industry are the production of food 
ingredients, such as sweeteners, dietary acids and enzymes by micro-organisms, increased 
production of food plants because of increased disease resistance and possibly, in the future, the 
production of lean meat. 
Crop impravement with the aid of genetic modification offers a number of advantages when compared 
with traditional breeding. The most important advantages related to the technique are: 
· the precision of the modification; 
- the ability to cross traditional borders in order to establish favourable genetic combinations. 
There are, however, some restrietlans when applying the technique: 
- the available transformation systems cannot yet be applied to every organism; 
- tor higher organisms it is nat yet possible to site the gene into the genome with suftielent accuracy. 
An additional problem bath in classica! as well as in 'molecular' breeding is the limited knowledge 
of physiology and composition in the different organisms befare and after breeding procedures. 
These factors are important tor the risk assessment of genetically modified food products. 
At present, genetically modified produels are largely in the research ar development phase. However, 
it is to be expected that some of these produels will soon be affered on the market Efforts are 
therefore being made to evaluate the risk to the consumer of such products. In the past tew years 
several proposals have been publishad tor (inter)national regulation with respect to the food safety 
of genetically modified agricultural products. The proposed guidelines are all intended to safeguard 
the safety of the consumer, while hamparing tree trade traffic as liltie as possible. 
The following organisations have already publishad proposals tor regulation: 
* International Food Biotechnology Council (1990) 
* Scandinavia: Nordie Working Group on Food Toxicology and Risk Assessment (NNT, 1991) 
* United Kingdom: Advisory Cammiltee on Navel Foods and Processas (ACNFP, 1991) 
* FAO/WHO (1991) 
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* Netherlands: Health Council (1992) 
In addition the following organisations have published draft guidelines: 
* Netherlands: Food Council 
* EEC: DG 111 lnternal Market and lndustrial Aftairs 
* United States: the Food and Drug Administration (FDA) is the only government institution that has 
so far published official guidelines in a 'Statement of Policy: Foods derived from new plant varieties' 
in 1992. These guidelines refer exclusively to new plant strains. 
An important common factor in the different proposals, with the exception of the EEC draft proposal, 
is the rejection of specific legislation for food products derived from genetically modilied organisms. 
lt is generally feit that these new food products can be evaluated within the framework of existing 
legislation which only requires specific clarification on a few points. 
In the following chapters, the different guidelines formulated so far and the (draft) proposals for 
regulation will be discussed briefly, tagether with an analysis of agreements and differences. This 
review of proposed guidelines is not exhaustive. A selection, representing the different views, has been 
made. For example, in 1990 the 'Food Sanitation lnvestigation Council' of the Japanese Committee 
for Biotechnology published draft guidelines for products obtained by recombinant-DNA techniques 
[Food Sanitation lnvest. Council, 1990]. These guidelines, however, only relate to products of 
genetically modified organisms in those cases where the modified organism itself does nat enter the 
food chain. Furthermore, in 1989 the 'Technica! Committee on Navel Foods' of ILSI Europe published 
a draft discussion paper on the subject in 1989 [ILSI, 1989]. These proposals can be found in the list 
of references. 
2.2 International Food Biotechnology Council (IFBC) 
The IFBC was established in 1988 and consists of some 30 (bio)technological companies in the food 
producing industry. One of the reasans for setting up the Council wastheneed for the food producing 
industry to have guidelines in order to be able to meet future requirements with respect to the safety 
evaluation of navel food products [Lindemann, 1990]. In 1990, the Council published the report 
'Biotechnologies and food: assuring the safety of foods produced by genetic modification' [IFBC, 
1990]. This document deals extensively with the risk evaluation of genetically modified food products. 
The aim of the Council was to set up scientific criteria tor the evaluation of the safety of products or 
ingredients derived trom genetically modified plants or micro-organisms. Applications of biotechnology 
in animal production are nat considered. 
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Figure. 1 Genetic modification of food products and guideHnes in relation to the food safety of 
these products. 
1973 First successful transformation experiment in micro-organisms (E. coH) 
1982 First successful transformation experiment in mammals (mouse) 
1988 First successful transformation experiment in plants (tobacco) 
Admission of the first GMO derived product onto the market (Switzerland: 
Kluyveromyces lactis derived chymosin). 
1990 Admission of the first GMO onto the market (Great Britain: Bakers' yeast) 
Calgene lnc. submits a report on the food safety aspects of the 
kanamycin resistance gene to the FDA as a request tor advisory opinion. 
Publication of the IFBC {International Food Biotechnology Council) report 
on the food safety of GMO derived products. 
1991 PubHeation of reports on the food safety aspects of GMO derived 
products by Scandinavian and British advisory committees and by 
FAO/WHO. 
Calgene lnc. submits a report on the food safety aspects of a transgenie 
tomato to the FDA as a request tor advisory opinion. 
1992 PubHeation of the report on the food safety aspects of GMO derived 
products by the Dutch Health Council. 
Publication of the FDA guidelines tor the food safety aspects of new plant 
variaties. 
The IFBC report includes a historica! review of food production and food safety evaluation through the 
ages and a chapter on classica! and navel genetic modification techniques used in plant breeding. 
An elaborate survey of present knowledge on composition with respect to macro and micro-nutrients, 
natura! toxins and antinutritional factors (ANFs) in erop plants is also included. An important starting-
point tor the IFBC is that sufficient knowledge of the composition of most food products is already 
available, so that the altered composition of genetically modilied products can be investigated. For 
risk evaluation the following bottle-necks are discussed: 
- the use of antibictic resistance genes as markergenes in transformation experiments. In agreement 
with the Calgene report on the samesubject [Calgene, 1990], it is stated that the use of antibictic 
resistance genes does not cause any risks unless heavy selection pressure is exercised on, tor 
example, micro-organisms in the Gl tract that have incorporated such an antibictic resistance gene 
by horizontal transfer trom the plant genome. This is more deeply discussed in Chapter 3. 
- pleiotropie effects, including position effects with respect to expression levels and insartion in 
coding and non-coding sequences. lt is stated that the usual Iabaratory and field experiments wil! 
bring possible pleiotropie effects to light. The tact that transposons and chromosomal 
recombination are natura! phenomena show that pleiotropie effects are not uniqualy related to navel 
genetic modification techniques. 
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- changes in the genetic code as a result of tissue cultures. With respect to this phenomenon it is 
also stated that the usual procedures offer enough opportunity to demonstrate possible deleterious 
genotypic changes. 
The IFBC has set up three decision trees tor different product categories in order to determine the 
kind of intermation to be supplied tor the product safety evaluation. These decision trees successively 
relate to: 
- Food ingredients derived trom micro-organisms. 
Risk analysis of these food products and ingredients should mainly focus on the genetic background 
of the organisms and constructs used, and on the existing knowledge concerning their toxicity. In 
these cases where it is known that both organism and construct do not code tor pathogenie and/or 
toxic elements, then the genetically modilied organism is considered to be safe. Other factors that 
are of importance and should be determined, are the genetic stability of the producing organism and 
the influence of process variables and regulating elements. The decision tree also indicates that no 
antibictic resistance genes should be present in the final organism. 
- Single chemieals and simple mixtures. 
In contrast to whole food products, single substances and simple chemica! mixtures can be relatively 
well characterised. Usually, standard taxicity testing will sufficiently safeguard the safety of food 
additives, micro-nutrients, residues and contaminants. One example of a substance produced by a 
genetically modilied micro-organism is the enzyme chymosin. Both new and permitled food 
ingredients, produced by means of recombinant-DNA techniques are considered safe if they contain 
no toxic or unknown components and if future exposure does not exceed existing limits. For this 
reasen the genetic background of both construct and production organism need to be well 
characterised. 
- Whole loods and other complex mixtures. 
Complex lood produels and macro-ingredients should also be basically regulated within the 
framewerk of existing procedures and regulations as applied to camparabie classica! food products 
and ingredients. Therefore, a genetically modilied tomato that has incorporated an anti-sense 
polygalacturonase gene sequence in order to imprave starage quality should, in principle, be 
regulated in the same way as a traditionally bred tomato. Evaluation should focus on the genetic 
make-up and composition of the product, when known and different trom the traditional counterpart, 
and on the estimated exposure. Knowledge concerning the genetic make-up implies thorough 
characterisation of the product and complete analysis and characterisation of the construct, which 
should not code lor toxic elements. Animal taxicity testing should only be performed in very specific 
cases, also in view of the anticipated difficulties with the practicability and interpretation of such 
studies. The combination of having to campose a balanced diet and the application of the safety 
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factors usually used in standard taxicity testing, is especially likely to cause major problems. Possible 
changes in composition can be determined by analytica! research on nutrients, natural toxins and 
factors that may interfere with the processing of the product. Wh en evaluating the product one should 
bear in mind the considerable variation in components that can exist within a species and at a 
specific developmental stage (ripening, storage). For example, the levels of tomatin can vary 
considerably depending on the stage of ripening of the tomato. An extra paragraph of the IFBC report 
is devoted to standard taxicity testing of complex products and the problems to be anticipated when 
performing these studies. 
In conc/usion it can be stated that the IFBC approach to the safety eva/uation of novel foods is a case-
by-case approach focusing on the product. The technique used to obtain the product is not 
considered to be of major importance when eva/uating the product as such. 
Finally, the report provides a survey on present American legislation tor (edible parts) of plants and 
plant products, processed plants, other biologica! ingredients, processing substances and chemica! 
additives. The IFBC states that the evaluation of novel foods obtained by means of genetic 
modification should primarily take place within the framework of existing procedures. New plant 
variaties should, in principle, not be registered. Notification of genetically modified variaties should 
be done on a voluntary basis. 
2.3 Scandinavia - Nordie Working Group on Food Toxicology and Risk Assessment. 
In 1988, the Scandinavian Advisory Committee on Food Problems (in which Denmark, Finland, 
lceland, Norway and Sweden participate) set up the Nordie Working Group on Food Toxicology and 
Risk Assessment (NNT). In 1991, this working group publishad the report 'Food and new 
biotechnology - novelty, safety and control aspects of foods made by new biotechnology' [Nordic 
Working Group, 1991]. 
The report provides a survey of new biotechnological techniques and assesses the impact of such 
techniques on the food producing industry [Klopper, 1991). The intlusnee of new techniques such 
as genetic modification and cell fusion on plants, micro-organisms and animals is analysed. 
Restrictions tor applying genetic modification are observed in all three categories. These restrictions 
mainly relate to: 
- limited knowledge of gene regulation 
- lack of stabie and efficient transformation systems 
- lack of suitable cloned genes. 
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Because of the importance of plants in our daily consumption pattern, genetic modification in plant 
breeding will, in the future, affect human nutrition. The working group states, however, that the 
borderline between traditional and advanced biotechnology is nat absolute and will therefore be 
ditticuit to regulate as such. lt is anticipated that Solanaceae (potato, tobacco and tomato) and other 
important dicotyledonous erop plants such as rapeseed and sugar beet will be the first genetically 
modified species to appear on the market, foliowed by Leguminosae (e.g. soy beans) and the first 
cereals (rice and corn). With respect to genetic modification in animals, the working group expects 
transgenie fish to be the first to enter the market The reason tor this assumption is that genetic 
moditication in fish would encounter fewer ethica! scruples. 
With respect to the safety of these new products when compared with their traditional counterparts, 
it is stated that in the latter (although assumed to be safe) high levels of natura! toxins aften cause 
acute or chronic taxie symptoms. The report provides an elaborate though nat exhaustive survey on 
natura! toxins. Within a species, large variations with respect to nutriant and toxin composition are 
aften observed. According to the report, new biotechnological techniques may have a beneficia! effect 
on, amongst other things, the concentration of natura! toxins. 
Risk evaluation of food products derived trom genetically modilied organisms should be based on 
the following three principles: 
1. Insartion of a genetic construct has an effect camparabie to mutagenesis. The insartion as such 
does nat cause specific problems. 
2. The biochemica! characteristics as well as the expression pattarn of the newly introduced gene 
product(s) are decisive tor risk evaluation. 
3. The new expression products may indirectly affect the metabolism of the host organism. Examples 
of such interterenee are downstraam effects after insertion, and competition tor amino acids. 
When evaluating risk, attention should also be given to genetic stability, genetic distance between 
the donor and host organism and the selection procedure. lt must be emphasised that it is essential 
to have analytica! raferences tor bath traditionally produced food produels as well as tor those 
developed via genetic modification. 
The working group proposes to relate the risk eva/uation of the new product to the relative novelty of 
the product. This can be determined by taking the present food supply as a reference. The working 
group suggests a case-by-case approach as the most appropriate. For the evaluation a tour step 
procedure is set up, camparabie to the decision trees proposed by other organisations. Each step 
can lead to acceptance, further experiments or rejection of the navel food. 
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The first step is to make an inventory of the knowledge of genetic background, composition and 
estimated exposure. Intermation with respect to composition should include data on levels of protein, 
peptides, fats and fatty acids, single and complex carbohydrates as well as on natura! toxins and 
antinutritional factors and other components such as enzymes, minerals and vitamins. This 
information, which is rather comprehensive, serves to campare the new product with its traditional 
counterpart. lf it is shown trom this initia! phase that the product cannot be considered as new it can 
be marketed directly. lf, however, it is found to be a new product a risk evaluation will be performed 
on the introduced gene product and possible secondary changes in composition. The gene product 
will be evaluated according to the existing regulations tor additives or contaminants. 
lf the final product is a complex one the next step wil/ consist of non-human teeding trials and 
metabolism studies of the product, bath in vitro and in vivo. A 90 day teeding trial in rats wil/ in all 
cases torm part of these studies. A safety factor of less than 1 00 in these toxicological studies will be 
acceptable whenever nutritional elements are studied. lt antinutritional factors or toxins are involved 
traditional safety factors tor additives will have to be applied. The final step wil I consist of experiments 
using human volunteers. These studies will focus on human allergy and intolerance. Finally, the 
working group recommends post-marketing research. 
These draft procedures are illustrated by a tew examples. In a transgenie tomato that has 
incorporated a gene coding tor the coat protein of tobacco mosaic virus, the natura! level of these 
proteins in non-moditied tomatoes will need to be analysed in order to determine the novelty of the 
product. A transgenie carrot on the other hand that has incorporated a gene coding tor a trypsin 
inhibitor into the genome will in all cases be considered as new, as this inhibitor does not naturally 
occur in carrot. In addition, the carrot is likely to be processed ditferently, compared with the donor 
organism of the inhibitor. 
The report recommends the possibility of identifying products produced by genetic modification. The 
working group advises that prior to approval of new products an identification methad will be 
recorded so that the product can be checked atter marketing. For products that do not enter the food 
chain a suggested identification methad is the incorporation of easily dateetabie markers in 
genetically modilied plants or animals. 
2.4 United Kingdom - Advisory Committee on Navel Foods and Processas 
In 1988, the Advisory Committee on Navel Foods and Processas (ACNFP) was established in the 
United Kingdom. The predecessor to this advisory group was the Advisory Committee on lrradiated 
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and Navel Foods, established in 1980. The ACNFP published their advisory report 'Guidelines on the 
assessment of navel foods and processes' to the Ministers of Health and Agriculture of the United 
Kingdom and the Head of Departments tor Health, Social Services and Agriculture of Northern lreland 
in 1991. In this report, the Committee proposes guidelines tor the producers of navel toods. For 
different product categories it is determined what intermation will have to be provided befare approval 
of the product tor the market can be considered. 
The ACNFP uses a braad definition of navel products and processes: all food products and 
ingredients that have so far not been available tor human consumption in the Uniled Kingdom in 
significant amounts and all processas that are new or significantly altered tor the production of food 
products. Products such as rapeseed oil and processas such as treezing and irradiation are 
theretore also subjeeled to the guidelines [Klopper, 1991 ). lf a product is obtained by making use of 
such a process the producer will have to notity the ACNFP. The ACNFP will subsequently perfarm 
a risk evaluation using the data provided by the producer. 
The proposed guidelines focus on determining possible changes in composition, especially with 
respect to nutrients and natural toxins. The guidelines are intended tor products obtained by means 
of classica! breeding strategies as well as by genetic modification. So far, producers in the United 
Kingdom can still decide whether the safety of navel foods is sufficiently guaranteed and whether or 
not new products are submitted to the Committee. 
The ACNFP has set up a decision tree to determine what intermation should be provided. This 
decision tree differs trom those set up by the IFBC in a number of ways. First of all the ACNFP tree 
includes bath products and processes. The produels are not classified in advance in different 
categories, but pass through the same decision tree. Finally, the tree does not result in guidelines 
tor the ad mission of the product onto the market, but delermines what intermation should be provided 
by the producer. The intermation to be supplied tor products derived trom genetically modified 
organisms largely corresponds with the information as required in other proposals: genetic 
background of the organism, data with respect to composition, especially nutrients and natural toxins, 
processing method, estimated exposure, effects of the genetic modification on the metabolism of the 
host organism and possible transter of the incorporated construct to other organisms. In addition, 
information on the stability of the genetically modified organism is explicitly required as well as a 
description of the tissues and organs where the incorporated genetic material is expressed. For 
example, an important factor when evaluating a genetically modified potato can be whether or not 
the incorporated gene is expressed in the potato tuber. In those cases where the estimated exposure 
shows that the new product will be consumed in large quantities human allergenicity studies should 
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be considered. The advisory committee stresses that the decision tree is not intended to be a mere 
checklist. The committee advocates a flexible approach whereby it can be determined which 
information is relevant tor the safety evaluation of each new product. 
The ACNFP therefore also proposes a case-by-case approach with clear guidelines in a single 
decision tree. The committee stresses the importance of transparency to the public and thus advises 
the risk evaluation procedures to be deposited in the British Library tor public inspection. The report 
provides eight examples of the information required tor the evaluation of novel foods according to the 
ACNFP decision tree. The examples vary trom a new application of a well-known product produced 
by an approved process, to the introduetion of genetically modified bakers' yeast. 
In an appendix the report stat es that with respect to the labelling of products derived from genetically 
modified organisms the following categories should be distinguished: 
- nature identical food products of genetically modified organisms 
- foods from intra-species genetically modified organisms 
- novel food products of genetically modified organisms 
- foods trom trans-species genetically modified organisms 
Labelling should in principle be required for the last two categories. lt should also be stressed that 
certain flexibility should be possible. 
2.5 Food and Agriculture Organisation/World Health Organisation 
In November 1990, a joint FAO/WHO consullation on the 'Assessment of biotechnology in food 
production and processing as related to food safety' took place in Geneva. In 1991, WHO publishad 
the conclusions of this meeting in a report [WHO/FAO, 1991). 
One of the aims of the meeting was to make a first move towards international consensus with 
respect to guidelines to safeguard the safety of products obtained by genetic modification. Th is could 
serve as a basis for national regulation. The meeting in Geneva can be seen as the first in a series 
of activities to achieve this effect. 
The report includes a survey of applications of genetic modification in 1} bacteria and fungi, 2} plants 
and 3} animals, foliowed by a consideration of the safety aspects. 
For the first category, micro-organisms, the report mentions a number of factors that could influence 
the safety of the final product: the genetic background of the original, non-modilied organism, the 
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characteristics of this organism and the methods used to introduce the desired traits. Functional 
marker genes will have to be removed in the final production organism. lntermediary organisms must 
also be well characterised. Faod-grade veetors are now being developed tor this purpose: veetors 
that can be used in food production without any health hazard. In this respect it is important that the 
genetic construct does nat code tor any taxie elements and that it is incorporated in a stabie way. 
The chance of {harmful) pleiotropie effects should nat be increased when compared with traditional 
breeding. A risk analysis concerning the effects of consumption on human health should be basedon 
an analysis of pathogenicity, taxicity and possible changes in nutrient composition in comparison with 
the traditional counterpart. The report also mentions the possibility of an increase in the number of 
allergie reactions by the introduetion of new or modified proteins. Knowledge of the induction of 
allergie reactions is limited and no reliable methods are yet available to determine allergenicity. 
Other factors that may affect safety are: 
- the termentalion process including substrates and other substances present, and the growing 
conditions; 
- the isolation procedure (and subsequent steps in the purilication process); 
- the final normalisation of the product. 
lt is important that in all cases production should occur under GMP conditions. lt is stressed that in 
a group of products with a similar genetic background there is always some variation. This is even 
the case where single substances are concerned. This should be considered when evaluating the 
safety of navel loods. 
The committee of experts advocates guidelines tor navel foods which correspond with existing 
FAO/WHO guidelines tor food additives, basedon a case-by-case approach. The committee prefers 
general principles based on scientific research to specilic reguiatien tor different product categories. 
For micro-organisms this implies that if the genetically modilied organism shows considerable 
resemblance to the traditional counterpart, relatively tew additional experiments will be necessary. 
In order to ask the right questions with respect to the safety of the second category of products, 
derived trom genetically modified plants, it is important to be familiar with the applied techno/ogy and 
the effects of the genetic modification. Potentlal risks should be related to the risks as they occur in 
traditionally bred plants. 
The report mentions some aspects that need to be addressed when evaluating the safety of 
genetically modilied plants. The genetic construct and possible expression products must be safe. 
lt is assumed that the genes incorporated in a stabie way will reach a fixed and predictabie 
expression pattern. Intermation about this expression pattern should be as detailed as possible. 
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In the report pleiotropie effects mainly refer to the metabolic effects of the introduced expression 
product. lt is anticipated that the biochemistry of the expression product will generally be sufficiently 
characterised to predict these metabolic effects. Moreover, these aspects do nat ditter substantially 
trom those in classica! breeding. Similarly, insertional mutagenesis cannot be considered as a new 
phenomenon in this respect. The cammiltee of experts stales that a changed composition with 
respect to natura! toxins and/or nutrients is in itself nat sufficient reason to block the marketing of the 
product. 
Compared with other reports on the subject the committee deals more specifically with possible 
toxicological and nutritional changes. Five possible toxicological changes are mentioned: 
* the presence ar increased content of natura! toxicants; 
* the presence of new expressed taxie materials resulting trom genetic modifications (e.g. 
biopesticides); 
* development of allergenicity; 
* accumulation of toxicants or microbial contaminants derived trom the environment; 
* changes in the availability of toxins as a result of processing. 
Changes in the nutritional value of the product can be the result of: 
* modification of major nutrients, micronutrients ar antinutrients in the food; 
* changes in the bioavailability of these substances; 
* changes in the nutritional components as a result of product processing. 
lt is thought that pertorming toxicological tests on complete, complex food products will cause major 
problems. Risk evaluation based on data of molecular, biologica! and chemica! characteristics of the 
product is therefore preferable. Analysis of the product may imply research on protein and amino acid 
composition as well as the composition of the sugar and lipid fraction, inorganic components and 
vitamins, naturally occurring toxins and antinutritional factors and starage quality. lf the food plant is 
a major constituent of the national diet, biologica! availability studies may be necessary. lf the 
intermation thus obtained is insufficient tor a proper food safety evaluation, animal studies ar, 
eventually, human studies will need to be considered. The latter would imply food trials with 
volunteers or limited introduetion onto the market The technology used, classica! ar recently 
developed, will delermine the amount and nature of the desired information. 
For the third category of navel foods, these obtained trom genetically modified animals, risk evaluation 
is presumed to be rather simple. Evaluation should mainly be based on risk assessment of the 
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expression product, the genetic construct and possible pleiotropie effects. Risk analysis of the 
expression product can be performed according to procedures used tor an exogenously administered 
equivalent. The construct should befree of viral sequences, thereby reducing the risk of gene transfer 
to the gut flora. According to the working group, potential pleiotropie effects will probably come to 
light if they affect the health of the animals. Unacceptably high levels of toxins in healthy animals have 
nat been recorded in the history of animal breeding and the chance of this occurring does nat seem 
to increase substantially by applying genetic modification. In lower vertebrales and invertebrates, 
however, this chance is possibly more significant and should therefore be considered as a factor in 
the risk analysis of produels derived from these animals. 
In products trom genetically modilied animals it is important to delermine possible changes in 
nutritional value. The composition of the navel food should therefore be analysed. The possible 
occurrence of food intalerance could also be an important factor. This could be caused by the 
introduetion of foreign genes but also by the expression of chimeric genes as a result of the 
association of transgenie and endogenic sequences. In general it will nat be necessary to perfarm 
taxicity tests on the complete product. 
The report advocates a scientifically based case-by-case approach. With such a flexible approach it 
is possible to include the latest scientific developments in the evaluation. The report also signals the 
necessity to set up well-informed databases of constituent compounds of food produels (nutrients 
and natura! toxins) and of gene maps of organisms used in food production. Finally, the importance 
of an etficient supply of information to the consumer is emphasised, with respect to the application 
of biotechnology in food production as well as to the safety of such products. 
2.6 Netherlands- Health Council and Food Council 
In 1988, the Minister of Agriculture, Nature Conservalion and Fisheries and the Parliamentary 
Secretary of State of the Mi nistry of Welfare, Health and Cultural Aftairs presenled a request tor advice 
to the Food Council with respect to 1) aspectsof new biotechnological techniques that require special 
government attention, and 2} ways of responsibly and effectively meeting the need tor consumer 
information. Toxicological aspects should nat be included in the advice as this subject will be covered 
by the Health Council. The Health Council therefore set up the Committee on Toxicological Aspects 
of Biotechnologically Prepared Products (referred to further as the Toxicological Committee) on the 
6th of April1990. The Toxicological Cammiltee considers bath biotechnologically produced medicines 
and lood products. The Biotechnology Committee was set up by the Food Council. Bath cammiltees 
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will deliver identical advice concerning subjects related to food safety evaluation. The advisory report 
of the Toxicological Committee to the Minister and Parliamentary Secretary of State of the Ministry of 
Welfare, Health and Cultural Aftairs has been published (Health Council, 1992). The report of the 
Biotechnology Committee is expected in the near future. Aspects to be covered in this report will be 
potential applications, consumer aspects, nutritional value and safety, and regulatory and marketing 
policy. 
At present, responsibility tor evaluating the safety of navel foods rests with the producer and no 
testing of this evaluation is done by the government. The Toxicological Committee advises that foods, 
obtained by means of recombinant-DNA techniques or cell fusion, should be evaluated on the basis 
of decision trees set up by the Cammiltee and that this evaluation should be assessed by the 
government at a later stage. The Toxicological Committee nat only advises with respect to 
toxicological aspects but also to product safety in generaL In the report the Committee states that new 
biotechnological techniques do not inherently cause more safety problems in comparison with 
traditional breeding, but there is still insufficient data on these techniques. 
To arrive at a safety evaluation of biotechnologically prepared products, the Toxicological Committee 
has set up tour decision trees with relation to: 
- single chemieals and chemically defined mixtures, 
- food produels of vegetabla origin, 
- food products of animal origin, 
- food produels and ingredients of microbial origin. 
The decision trees are mainly derived trom those proposed in the IFBC report with an extra one tor 
produels of animal origin. 
For the evaluation of products trom the first category the starting-points are identical to those of the 
IFBC decision tree tor the same category: sufficient knowledge on the genetic background and 
taxicity of the components of the producing organism as well as genetic stability and variatien in 
expression. Production under GMP (good manufacturing practice) conditions is demanded in all 
cases. In contrast to the IFBC report, the Committee does not stipulate the absence of genes which 
code tor antibictic resistance as a criterion tor release onto the market. This is thought to be 
unnecessary as the final product will be purified, thereby reducing the risk of gene transfer to a 
negligibly low level. In those cases where the final product contains uncharacterised components, or 
whenever this cannot be excluded, a 90 day feeding trial is stipulated. Another ditterenee in 
comparison to the IFBC decision tree is the tact that the latter would re-evaluate the ADI (Acceptable 
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Daily Intake) of the product if it is likely to be exceeded by consumption of the new product. Dutch 
regulations only offer this possibility in cases where the ADI is determined wholly or partly by factors 
that do not relate to the new product. 
The criteria as set up by the Toxicological Committee tor the safety evaluation of food plants are very 
similar to those of the IFBC. lf the traditional counterpart is a 'GRAS' product, knowledge of the 
genetic background of the insert and the influence of the insert on the composition of the product 
is of importance as well as the estimated consumption pattern. In order to detect possible changes 
in composition of food products of vegetabla or animal origin or other macro ingredients, it is deemed 
necessary to have an analytica! raferenee database. The Dutch Database on Food lngredients 
(NEVO) and the Database on Contaminants in Food Products (COBA) located at RIKILT-DLO could 
serve as a basis for such a database. Marker genes coding for antibictic resistance when 
incorporated in a stabie way, are deemed admissible. 
The most important ditterenee between the Dutch decision tree tor tood plants and the IFBC 
counterpart is that the tormer demands a 90 day teeding trial tor each new product. The Dutch 
decision tree only exempts those produels that have the p/ace of inseHion characterised to such an 
extent that it can be established that no detrimental effects to the metabo/ism occur that may affect the 
health of the consumer. 
The decision tree tor tood productsof animalorigin is added because according to the Toxicological 
Committee sufficient data are available to set up criteria tor this category of products. This decision 
tree evaluates products of genetically moditied animals as well as those of animals that have been 
treated with substances produced using biotechnology. The hazard in the latter category relates to 
contaminants of the preparatien as a result of the production process. The preparatien itself, or 
derived residues, will usually be evaluated according to the Veterinary Medicines Act. In products of 
animal origin it is equally important to be able to detect possible changes in composition as a result 
of genetic modification. In principle, the same starting-points apply as to products of vegetabla origin. 
On the other hand it is thought that the production animal will tunetion as a safety filter, for example 
when administering contaminated preparations. Furthermore, it is deemed unlikely that pleiotropie 
effects will cause the induction of taxie compounds in these products. The health status of the animal 
is considered an important criterion in this respect. 
With regard to the final category of products, food products and ingredients of microbial origin, it is 
not always clear whether a product should be considered as part of this or as part of one of the 
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preceding categories. Mushrooms, tor example, as a primary food product, will be evaluated as a 
food plant, whereas single substances produced by micro-organisms should in general be evaluated 
according to the second deelsion tree. 
The report stresses the importance of characterising the influence of production conditions on the 
organism and the strain used in addition to the criteria set up tor this category by the IFBC report. 
lt is known that under certain conditlans a usually non-pathogenie strain can produce toxins. No 
genes coding tor antiblotic resistance should be present in the organism, because gene transfer to, 
tor instance, the gut flora, and the resulting gene expression, cannot be excluded. The organism 
should be produced under GMP conditions. 
In contrast to the IFBC tree, the Dutch variant stipuiales an exact characterisation of the incorporated 
genetic construct and pays special attention to the effect of the new product on the nutritional status 
of the consumer. In addition, two extra questions are added so that the use of micro-organisms as 
problotics can be assessed. Finally, as the ultimata test, a 90 day feeding trial is demanded 
whenever insuftleient data are available about the place of insertion, in order to guarantee that the 
genetic modification has not caused any changes in the metabolism which could be detrimental to 
the consumer. 
Safety evaluation of these categories of produels should be carried out by, or tor, the producer and 
subsequently tested by an independent institution. This final control is also necessary as the deelsion 
trees allow room tor manoeuvre. After three years the criteria and the evaluation procedure should 
be reconsidered. 
2.7 EC- DG 111 lnternal Market and lndustrial Aftairs 
The EC Committee has recently accepted a draft proposal by the Directorale Generallnternal Market 
and lndustrial Aftairs (DG 111) tor the regulation of navel food produels and ingredients in the member 
states in order to prevent the obstruction of tree trade traffic as much as possible [EC, 1992). The 
proposal relales to all food produels and ingredients that have hitherto not been available tor large-
scale human consumption and to produels that have been considerably modilied by the production 
process with respect to composition, nutritional value and/or estimated consumption pattern. Food 
additives, flavours, extracts and produels that have been treated with ionising radlation do not fall 
under this regulation. 
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Fundamental principles tor releasing navel foods and food ingredients onto the market are: 
1. The products should be safe tor the consumer when consumed as food in the intended levels of 
u se; 
2. The products should nat mislead the consumer; 
3. The products should nat ditter trom similar foods or food ingredients that they may replace in the 
diet in such a way that their normal consumption would be nutritionally disadvantageous tor the 
consumer. 
Befare a new product is released onto the EC market the producer will have to demonstrata that the 
product camplies with the above mentioned criteria by using the results of scientific research carried 
out on the product. One or more qualified and independent experts (the Committee will set up a list 
of national experts) will have to confirm the conclusions of this research. Once these conditions have 
been met the product can be marketed provided the Cammiltee has been notified. This notification 
should include a summary containing all the information needed to demonstrata the safety of the 
product. The Committee will subsequently notify the competent authorities in the membar states. 
lf the new product entirely or partly consists of viabie organisms or if insufficient scientific data are 
avai/ab/e to demonstrata the safety of the product then the producer wil/ have to apply tor authorisation, 
as notification afone wil/ not be sufficient. 
Where a genetically modified organism is involved, evidence of approval trom the competent authority 
(the Ministry of Housing, Physical Planning and Environment in the Netherlands) tor research and 
development of the organism concerned as well as the complete technica! dossier necessary tor the 
risk analysis with regard to population and environment as indicated in the appropriate EC guidelines, 
should be added to the application. The Scientific Committee tor Food will take this dossier into 
consideration in their evaluation. The Committee will be consulled tor each new product falling under 
this regulation which could possibly affect the health of the consumer. 
The Cammiltee will intarm the member stales of an application tor authorisation. The member statas 
can subsequently offer advice and/or supply scientific information on the subject. The Standing 
Committee tor Foodstuffs will deal with the application for authorisation. This Committee will advise 
on measures proposed by the Committee within a term set by the chairman. This term will be fixed 
according to the urgency of the matter. The EC Committee will take the advice into consideration. 
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lf a member state opposes the release of a certain product onto the market it is possible to postpons 
or limit the release of the product in the country concerned. The other member states as well as the 
Committee should be informed immediately of this measure and of the reasans behind it. The 
Committee will have these reasans investigated as soon as possible by the Standing Committee tor 
Foodstuffs. The whole procedure will then be repeated. lf the Committee decides that the national 
measure should be modified or cancelled, the procedure willlead to the establishment of appropriate 
measures. 
2.8 OECD - Environment Directorate 
In 1990, the OECD set up the Working Group on Food Safety and Biotechnology within the Group 
of National Experts (GNE) on Safety in Biotechnology. The Working Group deals with scientific issues 
in the field of safety of new food products and ingredients. The Group focuses its attention on 
microbial, vegetabla and animal products that have been produced using biotechnological 
techniques. Food additives, contaminants, substances used in industrial processes and packaging 
materials are nat considered. The Working Group aims to deve/op scientific concepts to demonstrata 
whether these new produels have the same degree of safety as their traditional counterparts. 
In the introduetion of the draft report published in 1991, a historica! review was given of a number of 
aspects that have influenced food safety through the ages (OECD, 1991 ]. Variatien in the composition 
of nutrients and toxins is considered in the light of breeding processes to increase yield, imprave 
resistance and obtain better sensory characteristics, but also as a consequence of external, 
environmental conditions and of internal factors such as subsequent ripening stages. 
The Working Group has as a starting-point scientific principles that must be used with a certain 
amount of flexibility, taking into account the specific knowledge of the new product. This knowledge 
refers to the introduced characteristic, the consequences tor the nutritional value and level of toxins, 
the estimated consumption pattem and the way the product is prepared or processed. The Working 
Group advocates a case-by-case approach more emphatically in comparison to the other proposed 
evaluation procedures, and consequently does not propose structured guidelines in the farm of 
decision trees. 
ft is the apinion of the Working Group that new biotechnological techniques do nat require a 
fundamenrally different approach or new safety standards. The basic principle in the evaluation is to 
delermine the substantiaf equivalence between the new product and its traditional counterpart, if it 
exists. 
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Ta be able to determine substantial equivalence it is necessary to have sufficient data on bott1 the 
traditional and the new product, as well as on the incorporated genetic construct and its expression 
products. Other important factors are the methad of preparing ar processing and the estimated 
consumption pattern. 
The Working Group considers food products ar ingredients derived from organisms that have 
incorporated a well-characterised construct which, with a certain probability, does nat code tor taxie 
elements ar cause pleiotropie effects, equivalent to their traditional counterpart. Changes in 
composition ar possible pleiotropie effects can be detected by determining the levels of known 
components such as nutrients and toxins. 
Once substantial equivalence is established the product can be evaluated in a similar way to its 
traditional counterpart. Where na traditional counterpart is available and the concept of substantial 
equivalence cannot be applied as such, evaluation should be based on experience with camparabie 
substances ar products. 
The report of the Working Group gives nine examples of the application of the principles described 
above. The examples vary trom a traditional product such as LEAR (Low Erucic Acid Rapeseed) oil 
to products trom transgenie animals. First, tor each example, a conceptual survey is given of aspects 
that may be of importance tor the final evaluation. These factors can be rather diverse: according to 
the concept of continuity (if the product does nat change, but the consumption pattern does), the 
concept of temporality (tempora! changes in composition of the traditional product), the concept of 
variability (variation in toxin levels in the subsequent ripening stages), and the concept of substantial 
equivalence. Important factors are: 
- knowledge of the product 
- evaluation of the traditional counterpart. This is highly dependent on the nature of the product. 
- the possible availability of a database in order to be able to evaluate the traditional and novel food 
product. For example, the RIKILT-DLO Database on Contaminants in Food Products is mentioned. 
- knowledge of the new factor within the product 
- possible additional evaluation procedures, whenever this is considered necessary, with motivation 
tor these procedures. 
The approach of the Working Group is innovative in the sense that it focuses on scientific concepts 
rather than on technica! dossiers. The case-by-case approach is absolute. There is na deelsion tree 
to guide the evaluation of dossiers ar to assist those formulating specific conditions for approval. 
Furthermore, na speeltic requirements are described with respect to technica! details on the genetic 
construct and integration process needed tor the evaluation. 
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2.9 Uniled Stales - Food and Drug Administration 
In 1992, the Food and Drug Administration of the Uniled States publishad a Statement of Policy: 
Foods derived trom new plant variaties [FDA, 1992], thus becoming the first official institution to 
publish guidelines for the introduetion of products from genetically modified plants onto the market 
This statement relales to new plant variaties, irrespective of their mode of production, either by 
classica! ar advanced breeding techniques. The FDA states that existing legislation is sufficient tor 
the evaluation of products derived from plant variaties obtained by new techniques. At present new 
plant variaties are nat systematically evaluated tor food safety. The FDA is of the apinion that this wil/ 
nat be necessary in the future when new plant variaties obtained by means of advanced techniques 
wil/ be marketed. lt is stated that the legal status of the food product depends on the characteristics 
of the product and on how it will be prepared ar processed and nat on the methad of production. 
Knowledge of the latter can, at the most, be a factor to guarantee adequate evaluation of the final 
product. In speei/ie cases the FDA wil/ require a pre-market review. In all cases the producer remains 
responsible tor the safety of the product tor the consumer. 
In the United States, the marketing of food additives is reguialed under the Food Additives 
Amendment. For food additives a pre-market safety evaluation is required, unless it is a GRAS 
substance or can be recognised as such. A limited list of GRAS substances has been publishad by 
the FDA. Producers are advised to contact the FDA if they are of the apinion that a certain substance, 
nat listed as GRAS, should be considered to be sa. 
The FDA states that an inserted gene and its expression product should be considered as a food 
additive. This implies that in principle a pre-market evaluation should be done, unless it is a GRAS 
substance ar can be recognised as such. Same other aspects of new plant varietles that possibly 
need to be evaluated in order to be able to determine the food safety of the products are: u nforeseen 
effects, such as pleiotropie effects, possible changes in levels of natural toxins and of important 
nutrients, possible (increased) allergenicity and the presence of antiblotic resistance genes as 
selection markers. 
Labelling is considered necessary in those cases where the consumer may be mislead. This could 
be the case, for example, if a new product differs from its traditional counterpart to such an extent 
that the traditional name na langer relates to the modified product. Labelling will also be required if 
an allergen has, ar has possibly, been introduced into a new product. In general, however, the FDA 
is of the apinion that labelling of products obtained by advanced breeding techniques is nat 
necessary. 
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Several decision trees are included in the statement to guide the producer in the evaluation of a new 
product. Six decision trees have been set up relating to the safety evaluation of the donor plant, the 
incorporated fragment, the introduced proteins, introducedor modified sugars, introducedor modified 
fatty acids and a general decision tree combining these different elements. On saveral points within 
these decision trees the producer is advised to consult the FDA experts if the status of the product 
is nat clear. The consequence of this, however, is that the final criteria by which the FDA evaluates 
new products, remain rather vague. 
A complicating factor in American legislation is the division of tasks between the different institutions. 
For example, the responsibility tor marketing pesticides rests with the EPA (Environmental Proteetion 
Agency). At present, a genetically modified insect or virus resistant plant should be evaluated by the 
EPA as far as the introduced resistance is concerned. This implies that food safety aspects of the 
introduced gene and marker genes, if present, should also be evaluated by the EPA. 
2. 1 0 Conclusions 
In the previous sections, guidelines as proposed (in draft) by different organisations, for the 
introduetion of genetically modified products have been summarised. In some cases these guidelines 
are part of existing guidelines for products produced by more traditional techniques, in other cases 
guidelines are proposed as a specific completion of already existing guidelines. All guidelines relate 
to products obtained by means of a number of specific techniques, especially recombinant-DNA 
techniques. 
All guidelines tor the risk evaluation of the introduetion of new products are based on a case-by-case 
approach. This does nat mean, however, that there are no major ditterences between the different 
approaches. There is considerable variatien in the room tor manoeuvre between the different 
guidelines. Same proposals for risk evaluation are based on dividing new products into different 
categories (especially the IFBC and the Dutch advisory organs). The OECD draft proposal applies 
the case-by-case principle in the most far-reaching way. In this sense, the more recent proposals 
tend more towards the case-by-case approach. 
The proposal of the Dutch Health and Food Council is very similar to the IFBC proposal: evaluation 
focuses on the product and the new produels are divided into different categories. The report of the 
Scandinavian advisory cammiltee also tends to evaluate the product and nat the process. The 
products are, however, nat divided into categories, at least nat at the beginning of the evaluation 
process. The room tor manoeuvre seems to be rather limited with these proposals. 
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Figure 2 Elements in proposed evaluation strategies. 
A 8 c D E 
IFBC + + - - -
Skand.NNT - + ? + + 
VK-ACNFP + + - +I- + 
FAO/WHO - + + 
- -
NL-Health Council + + - + 
-
EG ? + + ? ? 
OECD - + - - -
VS-FDA + + - - + 
A: makes use of deelsion trees (the nature of these deelsion trees may ditter slightly) 
B: case-by-case approach 
C: new legislation necessary 
D: risk analysis including feeding experiments 
E: allergenicity as a factor in risk analysis 
F: responsibility of the producer 
+/- in speeltic cases 
F 
+ 
-
+ 
? 
-
-
? 
+ 
The British proposal does nat divide products into categories. Bath products and process are 
evaluated according to the same scheme. The British deelsion tree is nat a deelsion tree as such: it 
can be used as a gulde tor the producer to find out which data need to be supplied tor the safety 
evaluation. No consequences are attached to these guidelines and the room tor manoeuvre in these 
guidelines is therefore considerable. 
Risk evaluation as proposed by the FAO/WHO werking group aims at bath the product and the 
process used. The technology used determines the amount and the nature of the information to be 
provided with relation to the product. Although risk analysis is described per category of new 
products, the werking group advocates generally applicable guidelines on a scientitic basis instead 
of speeltic guidelines tor different product categories. The werking group does nat make use of a 
deelsion tree. The room tor manoeuvre Is considerable. 
The EC guidelines are nat guidelines in the same sense as in the ether proposals. In the proposal, 
the evaluation procedure is described and a category of products indicated that, in general, will need 
to fellow the authorisation procedure. 
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The OECD, as already stated, goes the furthest in applying the case-by-case approach. This 
approach is more in agreement with that of the FAO/WHO. 
The FDA, finally, also applies a case-by-case approach, in which the producer is oftered six decision 
trees to enable him to make a risk evaluation of a new product. In all cases the producer remains 
responsibis tor the safety of the new product. lf these decision trees do nat offer enough information 
about the legal status of the new product, the producer is advised to consult the FDA. The final 
criteria of the FDA tor the introduetion of new produels therefore remain rather vague. Special 
attention is paid to the introduetion of antibiotic resistance genes and the possible introduetion of 
potent allergens. The FDA is still studying these subjects. As, in principle, no authorisation procedure 
is necessary tor the introduetion of genetically modified products, the FDA advocates a regulation of 
these produels that is fundamentally different trom the regulation proposed by the EC and OECD. 
As the room tor manoeuvre of most proposals is quite considerable, it is nat clear to what extent the 
introduetion of these guidelines will result in conformity of evaluations of new produels in the different 
countries. Several organisations have already declared themselves to be in favour of genera!, 
international guidelines with relation to navel foods. However, the pubHeation of the EC draft 
regulation and the FDA guidelines in the United States show that world-wide agreement on the 
subject will nat be reached in the foreseeable future. An important advantage of generally accepted 
guidelines would be that the introduetion of these new produels would nat have an adverse effect 
on tree trade traffic. lt is therefore important tor international organisations to take the lead in the 
discussion on guidelines tor produels and product ingredients derived trom genetically modified 
organisms. 
Risk evaluation of single substances and simple chemica! mixtures will nat usually lead to major 
ditterences in risk evaluation. Also, in relation to the evaluation of genetically modified micro-
organisms, no major contrasts can be obseNed in the different proposals, although gaps in 
taxonomie knowledge may cause some difficulties in the evaluation [Franklin, 1 988). 
lt can, however, be foreseen that when introducing evaluation strategies tor transgenie vegetabla and 
animal produels as described in the foregoing sections, there will be major ditterences in the 
evaluations. The international organisations in particular advocate evaluation based on molecular and 
biochemica! analysis, camparing the new product with its traditional counterpart. The FDA also 
advises producers to follow the analytica! approach. The Scandinavian and Dutch reports, on the 
other hand, tend to base the evaluation on taxicity tests of the product. 
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The reports favouring an analytica! approach indicate that the performance of taxicity tests in animals 
is an elaborate and time-consuming procedure resulting in data that are ditticuit to interpret These 
taxicity tests should therefore only be carried out after ample consideration. 
lt is nat clear whether the chance of insertional mutagenesis, with detrimental effects tor food safety, 
increases with the application of genetic modification compared with traditional breeding techniques. 
In traditional breeding techniques tissue culture steps are also aften part of the procedure. In thirty 
to forty per cent of the cells this could lead to changes in DNA structure causing morphologically 
dateetabie changes (Van den Bulk et al., 1990). An extra argument against the standard performance 
of animal tests is the possible variation in genetic composition within the genetically modified variety. 
The variety to be marketed is aften the result of back-crossing a number of successful transformant 
lines with the unmodified variety. An analytica! approach would probably furnish more information on 
variatien in biochemica! composition and on possible toxicological consequences than anim 
al tests. 
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3 BOTILE-NECKS 
3.1 Introduetion 
Whenever a safety evaluation of products from genetically modified organisms is performed, several 
difficulties may be encountered. These are mainly related to the modification and only in a few cases 
to the techniques applied. Same of these aspects will be discussed briefly in this chapter. 
3.2 Transformation systems. 
The different transformation systems that have been developed all aim to transfer genetic information 
trom one organism to another. Even when a gene from the same species is involved, reproduetion 
will usually occur in a micro-organism. The most frequently used transfer system in plants, the 
Agrobacterium tumefaciens system, also uses a micro-organism as vector. 
Although damage to the cell will differ considerably, depending on the system applied, selection on 
the basis of morphologic characteristics will, on the whole reduce these diJterences to camparabie 
values. In other words, if a certain transformation system causes major damage to the genome of the 
cell, changes will soon be morphologically detectable and can therefore be rejected. Other, more 
subtle, genetic changes as a result of the insertion will be camparabie to changes caused by other, 
more elegant transformation systems. A transformation system will therefore be used once it has 
proved to be efficient. Future improvements in existing systems, for example by applying homologous 
recombination can, however, be an important factor with respect to safety evaluation. When 
homologous recombination is applied, a DNA fragment can be incorporated on a previously 
determined site in the genome. The chance of insertional mutagenesis will therefore be considerably 
reduced. There are no techniques yet available to establish homologous recombination in plants. 
Specific changes in plants, caused by genetic modification by the Agrobacterium tumefaciens system, 
cannot be ruled out. Field experiments have shown that various species show a weaker growth 
pattern independent of the nature of genetic modification. Experiments are currently being performed 
with original Agrobacterium tumefaciens strains to determine whether this effect also occurs in these 
strains. Another possible explanation forthese observations could be to do with the secondary effects 
of the generally used marker gene npt 11. 
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3.3 Marker genes. 
In order to be able to recognise successful transgenesis experiments it is necessary to introduce a 
secend gene, the marker gene, with the target gene. A gene can lunetion successfully as a marker 
gene if its expression product is demonstrabie in the earliest stage after the experiment. Several 
genes that result in resistance to a number of extern al factors, such as antibictics or herbicides in the 
medium, meet this requirement. A further advantage of using these compounds is that unsuccessful 
experiments are directly rejected. 
Neomycin phosphotransferase 11 (npt 11) gene ( = amineglycoside (3') phosphotransferase 11, APH (3') 
11) is by far the most applied marker gene in genetic modilication experiments. The expression 
product results in resistance to, amongst ethers, neomycin and kanamycin. These antibictics are used 
in human medicine only on a limited scale, whereas in veterinary medicine they are used extensively, 
especially in cattie and pig breeding [Bijvoet, 1 991]. Amineglycoside antibictics are administered tor 
infections caused by anaerobic gram-negative bacteria. Anaerobic bacteria (99% of the gut flora) are 
naturally resistant to aminoglycosides due to the lack of respiratory quinenes and binding sites 
necessary tor the transport of antibictics to the cytoplasm. 
On the subject of the food safety of this gene as a marker gene tor the genetic modification of 
tomatoes, the gene technology company Calgene lnc. has written a rather elaborate report that has 
been submitted to the FDA for approval. The report is based on theoretica! considerations. Practical 
research in this field is still very limited. This report states that the marker gene could be harmful in 
three different ways: as a result of direct toxicity, by immunological effects (allergenicity) or by 
reduced effectivity of medical treatment. Taxicity of the DNA as such is nat likely. The report states 
that no indications have been found of possible transformation of gut epithelial cells in vivo. These 
epithelial cells are completely differentiated and have a half-life of five to eight days. Transformation 
of these cells will have such a limited effect that treatment with antibictics will nat be endangered. 
Furthermore, no cases of spontaneous transformation of a bacterium strain in the human Gl tract are 
known or can be found in experiments done under similar conditions. The report describes a risk 
analysis tor such a transformation and draws the conclusion that in a worst case scenario one 
bacterium of the gut flora will become resistant to neomycin and kanamycin in one out of every 
thousand people consuming an average daily amount of genetically modilied tomatoes. Compared 
with the huge numbers of aerobic bacteria that are already resistant to these antibictics this seems 
to be negligible [Calgene, 1990]. 
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Concerning the effects of the gene product, the Calgene report states that the introduetion of 
resistance genes is nat likely to have any immunological effects, because the gene is already present 
in the gut flora and because mutations in microbial cells cause a constant flux of new protein and 
nucleic acid molecules. Reduced effectivity of the antibictic is thought unlikely as the enzyme is 
rapidly degraded in the Gl tract. Furthermore, tor effective inactivation of, tor example, kanamycin, 
ATP is necessary. ATP is probably not available in the Gl tract [Calgene, 1990). 
A methad to remave the antibictic resistance gene trom the plant genome after a successful 
transformation experiment has recently become available. For this purpose an extra gene is 
introduced which accomplishes the remaval of the npt 11 gene. The extra gene is subsequently 
removed by cross-breeding [Moffat, 1991). However, this results in considerable delay in the overall 
breeding procedures. 
In addition to antibictic resistance genes, herbicide resistance genes are also used as markergenes 
on a limited scale. Bath kinds of genes have the advantage that, tagether with rapid identification of 
successful experiments, direct selection can take place. Ta date only a tew examples are known of 
market-ready products in which a herbicide resistance gene has been incorporated as marker gene. 
A (toxicological} risk evaluation of these genes and gene products has nat yet been performed. 
In micro-organisms, scientists have succeeded in developing methods to remave an essential gene, 
necessary tor normal growth and reproduction, trom the genome. This gene is subsequently re-
introduced into the genome tagether with the (transgenic) target gene. The gene thus functions as 
a marker gene. lt seems only a matter of time befare research will produce similar systems tor higher 
organisms. lf na major arguments arise trom a toxicological evaluation, it would seem acceptable to 
allow the use of resistance genes as marker genes in the meantime. At the same time, research to 
find alternative systems should be stimulated, as well as post-marketing research on the effects that 
the introduetion of these marker genes will have on the antibictic resistance of the gut flora. 
3.4 Regulator elements. 
lt seems only a matter of time befare it will be technically feasible to genetically modify every plant, 
whether mono ar dicotyledonous. The limiting factor tor the number of new applications of these 
techniques will increasingly be the identification and isolation of genes of interest and regulator 
elements. Modification of a product of secondary metabolism (nat a protein) requires considerably 
more fundamental biochemica! knowledge than is currently available [Lindsey et al., 1989). Progress 
in research to identify specific regulator elements such as tissue ar developmental stage specific 
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promotors and enhancers is also rather slow. Furthermore, specific activity of a regulator element in 
one species does not necessarily indicate similar activity in another species. lt is, however, possible 
to manipulate promotor activity by replacing specific sequences within the promotor (Schöffl et al., 
1990). 
Only a tew tissue-specific promotors have been identified. Examples of such promotors are the patatin 
promotor (expression in the potato tuber), the phaseolin and conglycinin promotor (cotyledon), 
glutenin and 13-hordein promotors (endosperm) and a a-amylase promotor (aleuron) [lindsey et al., 
1989). 
In addition to these specific promotors there are several constitutive and inducible promotors. The 
constitutive promotors used mostoften are the nos (nopalin synthase) and CaMV (Cauliflower Mosaic 
Virus) promotors. The latter, on average, causes a thirty times higher expression rate compared with 
the former. The inducible promotors identified so far are sensitive to light (promotors of the small 
subunit of Rubisco and of chlorophyll binding protein), to anaerobiosis (of alcoholdehydrogenase 1), 
to heat shocks (heat shock proteins), to fungal factors (chalconsynthase) or to injuries (potato 
inhibitor 11) [Lindsey et al., 1989). 
A group of promotors currently the subject of extensive research are those of the heat shock proteins 
(hsp). This is a group of proteins that are expressed by a sudden increase in temperature and 
possibly a lso under the intlusnee of other stress inductors. At the same time the translation efficiency 
of other mRNAs is temporarily reduced. This reaction probably protscts the cell against the effects 
of heat stress. Although the hs proteins consist of different families and show considerable diversity, 
strong similarity can be seen among these proteins in different organisms. The exact tunetion of the 
hs proteins has nat yet been described. They seem to be independent of temperature, which is 
important tor the development of the organism. Within the promotors of the hs proteins, sequences 
have been found that are important tor heat induction and tor increase of expression. Knowledge of 
these elements has enabled scientists to design promotors that can achieve higher expression levels 
(Schöffl et al., 1990). 
lt is also possible to increase expression levels dramatically by duplicating promotors and enhancers 
in transgenie plants. Applications of these new regulator element (target gene) combinations further 
increase the necessity tor research on systems tor metabolite profiling and component analysis. As 
already stated, it is feasible that a promotor causes tissue or developmental stage specific expression 
in one organism while causing constitutive expression in another. lntermediary scenarios, tor example 
expression in several but nat all tissues, are also feasible. lnsight into this is important for a proper 
safety evaluation. 
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3.5 Component analysis and metabolite profiling. 
lt has been shown in the past that ongoing selection tor disease resistance in classica! breeding 
programmes can lead to unacceptably high levels of natural toxins. One example of this is the high 
solanin content in resistant potato varietles [Anderson et al., 1987; Mahon, 1990). Fundamental 
knowledge about the biochemica! background of natural resistance is aften lacking. lt is therefore 
important to perfarm a component analysis on new varieties, produced by either classica! ar new 
breeding techniques. In this way, changed levels of natural toxins and important nutrients can be 
detected. The OECD considers this as one of the most important aspects of risk evaluation and has 
tor this reasen introduced the concept of substantial equivalence. This concept is used as a 
conceptual basis tor the risk evaluation of products that only ditter in a single ar tew aspects trom a 
camparabie classica! product [OECD, 1991). 
Figure 3 Basic elements in the risk analysis of genetically modified complex products. 
Exposure: 
- to newly introduced proteins, including marker proteins 
- to the whole complex product 
Substantlal equivalence: 
- to the new product in comparison with the traditional counterpart 
[DNA analysis: 
- of the place of insartion and flanking regions) 
(lmmuno)toxicity: 
- of the newly introduced proteins, including marker proteins 
- of the traditional components, if significantly elevated. 
In various reports, including that of the FDA, this concept has been further evaluated and it is stated 
that the level of natural toxins should nat exceed similar levels in other edible varieties of the same 
species [FDA, 1 992; Stewart, 1 992]. Other reports, however, indicate that a changed composition with 
respect to nutrients or natural toxins does nat necessarily imply that these products can no langer 
be considered safe. The preparatien process of the product is also important tor risk evaluation. lf 
this process aims to eliminale the natural toxins, tor example by boiling, then this should be 
considered in the risk evaluation. 
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lt is generally expected that as a result of genetic modification in plant breeding all new agricultural 
products, produced by either traditional or advanced biotechnological techniques, will be viewed 
more critically. Biotechnology can thus contributs to increased consumer awareness. Because of this 
there is an increasing need tor adequate methods of analysing complex products. lt is also important 
that existing databases, in relation to food components, be combined as soon as possible, so that 
modification analysis of complex products can (tor the time being?) concentrata on known nutrients, 
toxins and antinutritional factors. In this way more insight can be gained into the components of a 
product, but also into the variation in composition depending, tor example, on variety, stage of 
ripening or sampling location. 
So far, little is known about the variation in components of different variaties. In order to be able to 
assess the increased or decreased taxicity of a new product it will be necessary to gain more insight 
into biochemica! changes that result trom a certain genetic modification other than the intended on es. 
For this purpose databases will need to be set up to supplement existing data with that trom specific 
research projects. 
An alternative system tor component analysis is metabolite profiling, whereby an image of the new 
product is obtained using techniques such as NMA, LC(GC)-MS, (N)IR. This image can be compared 
with that of the classica! counterpart of the new product as well as with profiles of products of other 
variaties. lt will nat be necessary to identify individual compounds in the spectra: the profile as such 
will provide information on possible changes in biochemica! composition. lt in this way large 
ditterences between the classica! and the new product are found, additional experiments to 
characterise the biochemica! nature of these ditterences can still be considered. lf these ditterences 
can only be seen in a single or a smal! number of transformant strains it will in general nat be 
advisable to continue with such strains. In this way metabolite profiling can be of use early on in the 
breeding programma. 
3.6 lmmunotoxicity. 
One aspect that is mentioned in several reports and which is considered to be an important factor 
in risk assessment when introducing a protein into the food chain, is the immunotoxicity of that 
protein. Immunetaxicity is a relatively new field in experimental research. A protein, or a protein 
fragment, can cause an immunological effect when a certain epitape is introduced unchanged or 
when the protein, or fragment, has been modilied in such a way that an effect can occur. lndeed, it 
seems that food intalerance (non-immunological food over- sensitivity) occurs more frequently than 
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food allergy. Food intalerance may be the result of the lack of specific essential enzymes, but other 
causes cannot be excluded. The underlying cause of food intalerance is seldom known and tew 
research projects are devoted to the subject [Health Council, 1991). Now that in the near future a 
number of new compounds may be introduced into the hu mandiet in considerable amounts, it is time 
to intensify research on allergenicity and on the induction of intolerance. 
Saveral different specialised immune tissues and cells are located in the Gl tract. The most important 
of these are Peyer's patches (grouped T and B lymphocytes in the smal! intestine), over which 
epithelial cells are folded (M cells) that are likely to have a presenting function. Peyer's patches 
contain precursors tor secretory lgA. Other important cell types are the intra-epithelial lymphocytes, 
the lamina propria lymphocytes, macrophages and mast cells. Testing systems tor immunotoxicity 
are mainly based on changes in the composition of these immune cell populations. A clear 
description of the different farms of immune response after antigen stimulation can be found in the 
Health Council report on immunotoxicity (Health Council, 1991). This report reviews the existing 
testing systems tor determining the immunotoxicity of individual compounds. The strategy proposed 
in the report to delermine the immunotoxicity of (new) compounds is mainly based on the multiphase 
system proposed in the 1987 IPCS report. lndications for immunotoxicity in the first phase will lead 
to second phase research with more specific tests. However, validaled testing systems to investigate 
the antigenie characteristics of compounds in relation to food allergy are not available. A testing 
system considered to be promising is the popliteal lymph node (PLN) assay which is based on a 
lymphoproliferative reaction in the popliteal lymph node. This test used to predict the ability of 
compounds to cause contact dermatitis and auto-immune disease has so far produced good results. 
lt is not yet clear, however, whether it can be adjusted to identify food allergens. The main problem 
in the development of useful testing systems is the considerable variation in sensitivity to 
sensibilisation and subsequent allergiesin individuals (Health Council, 1991; Schou, 1990).1n addition 
to the testing systems mentioned in the report, post-marketing surveillance and epidemiological 
research is still advised. 
3. 7 Post-translation modification. 
Post-translation modification could be a factor in bath taxicity and immunogenicity. The exact effect 
of, tor example, glycosylation on immunogenicity, receptor recognition, degradation rate and 
degradation products of a protein, is not known. There are, however, indications that this effect 
should not be underestimated [Alexander et al., 1984; Goldburg et al. , 1990; Mahon, 1990). Other 
farms of post-translation modification, such as phosphorylation may in certain cases also cause 
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toxicological effects. On the other hand the lack of post-translation modification could also cause 
toxicological effects. The latter may occur if a eukaryotic gene is expressed in a prokaryotic organism, 
tor example chymosin produced by a micro-organism (Mahon, 1990). More research is required on 
this subject. 
3.8 Labelling 
Several reports briefly discuss the labelling of genetically modilied products, but they do not always 
agree on the category of products which should be labelled when marketed. Some advisory 
committees are of the opinion that all produels obtained by genetic modification should be labelled 
to guarantee the consumer treedom of choice. Other institutions, including the FDA, consider labelling 
only necessary if a product is modilied in such a way that consumption of this product could be 
harmful to a specific group of consumers. A modification that introduces a known allergen, tor 
example a peanut allergen, into a product not already containing this allergen, would thereby be 
subject to labelling (FDA, 1992; Andersonet al., 1987). 
lf labelling becomes obligatory tor specific categories of products, analytica! methods will be 
necessary in order to make verification possible. lt is clear that good identification methods will be 
necessary to make effective inspeetion possible. lt is not clear how measures tor rapid identification 
can be taken without introducing an extra risk factor, tor example the introduetion of an extra 
identification sequence. ldentification will, therefore, need to be product specific. lf a cisgenie gene 
is incorporated, inspeetion by means of biochemica! analyses will not be sufficient and testing 
systems at DNA level will need to be developed. As every transformant strain is in principle unique, 
these systems will have to be based on more general characteristics of genetic modification, thereby 
possibly reducing the sensitivity of the test (Jones, 1992]. Other proposals, such as the introduetion 
of genes that cause marked characteristics to organisms not suitable for consumption, seem less 
realistic (Anderson et al., 1987). 
Another condition tor labelling is a good definition of, tor example, genetic modification and related 
terms. lt has proved ditticuit to draw an exact line between different categories of products. 
lt is clear that informing the consumer is of major importance tor acceptance of the new products (De 
Greef, 1991 ; Middlekauff, 1990; Hamstra et al., 1989). In the Netherlands, discussion on this subject 
is currently in progress. So far it seems that the results are in accordance with the recommendations 
of the British report: no labelling tor produels identical to those already in the human diet. A 
provisional agreement states that the use of microbial chymosin, identical to the chymosin obtained 
trom calves, does not need to be mentioned on the packing. 
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4 CONCLUSIONS AND RECOMMENDATIONS 
The following conclusions can be drawn trom the foregoing chapters: 
* The proposed guidelines tor evaluating the food safety aspects of food products obtained by 
recombinant-DNA techniques show great similarity, with ditterences only on minor aspects. 
Important agreement exists on considering the transgenie expression product to be an additive. 
Taxicity and exposure levels should be determined. To identify possible pleiotropie effects in 
complex products, all guidelines apply the principle of camparing the composition of the new 
product with the composition of its traditional counterpart (substantial equivalence). Ditterences 
between the proposed guidelines tor complex products are mainly with respect to the necessity tor 
additional tests to determine, tor example, taxicity and allergenicity. 
Criteria tor approval of a new product are far trom clear. To gain more insight into these criteria and 
to screen guidelines for imperfections, it will be necessary to evaluate several test cases according 
to a selection of the proposed procedures. The results of these evaluations will be valuable when 
trying to reach an optimal evaluation strategy. lt is proposed to start with evaluating products 
according to the guidelines proposed by the Dutch Health Council, OECD and FDA. 
* The case-by-case approach is generally accepted and seems to be the best one tor evaluating the 
considerable variety of genetic modifications in the various products. Moreover, by applying a case-
by-case approach the latest scientific findings can be included in the evaluation, thereby 
guaranteeing maximum safety of the new products. One disadvantage of the case-by-case 
approach is that it may require more effort to safeguard uniformity of evaluation. Communication 
with the consumer could also be affected by this approach and the evaluation procedure may take 
more time. lt is feasible that, once sufficient experience with the evaluation of novel products has 
been gained, categories of products can be indicated which can be evaluated according to a 
simpler procedure if knowledge on product and insert is sufficient. 
* One discussion point is whether feeding trials with the complex product should be part of the 
standard toxicological risk evaluation. The more recent reports advocate a more analytica! approach 
in the risk analysis procedure. In view of the problems encountered with animal experiments 
(difficulties in composing a balanced diet, low safety factors), the choice of an analytica! approach 
appears to be justified. At present only classica! feeding experiments are available to test the 
complex product toxicologically. An alternative to these experiments would in theory be an 
analytica! approach at the DNA (RNA) level or the application of systems such as component 
analysis or metabolite profiling. However, fundamental knowledge on the functioning mechanisms 
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at DNA level is largely lacking. Component analysis and metabolite profiling seem to offer enough 
perspeelive to obtain an impression of changes in composition after genetic modification in a 
relatively simple way, while also sparing Iabaratory animals. lf this analytica! approach cannot 
generats sufficient data on the safety of the new product, additional feeding experiments can still 
be considered. 
* There are some consequences if the analytica! approach is chosen. Systems to test the concept 
of substantial equivalence (component analysis and metabolite profiling) will need to be developed 
and validated. Databases will have to be set up in order to perfarm risk analyses more efficiently. 
These databases will need to provide intermation on the presence and variatien of nutrients and 
antinutritional factors in specific varieties of food plants, including the different variaties. 
* In some experimental disciplines additional fundamental research is necessary in order to perfarm 
risk evaluations more efficiently. lncreased research efforts are especially necessary in the 
immunotoxicological, gut toxicological and fundamental molecular biological (regulator elements, 
gene-gene interactions) disciplines. lmproved knowledge on plant physiology is also of importance 
tor the safety evaluation of new varieties. Finally, additional knowledge of the phenomenon of post-
translation modification would be extremely valuable. In the short-term, research in the fields of 
post-translation modification, immunotoxicology and gut toxicology of complex products, whether 
modified or nat, needs to be stimulated in order to imprave existing evaluation procedures. 
Moreover, the development of in vitro systems could reduce the number of Iabaratory animals 
involved. 
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TEAMS AND ABBREVIATIONS 
Antisense RNA: RNA coded tor by the complementing, non-coding DNA sequence of a gene. lt is 
thought that this RNA farms a complex with the RNA coded tor by the coding DNA sequence of the 
same gene, thereby inhibiting translation and subsequent expression of the gene. 
Cisgenesis: process of genetic modification incorporating a gene of the same species. 
DNA (deoxyribonucleic acid): the complex, biochemica! substance that genes consist of. DNA 
contains the genetic information in most living systems. The order of the bases that farm part of DNA 
determines what the expression product of the gene will be, if any. 
Electroporation: technique to introduce DNA sequences in a cell as a result of a ditterenee in 
sleetrical potential. This ditterenee in potential facilitates the transfer of DNA sequences through the 
cell wall. 
Enhancer: DNA sequence that may enhance the expression of a certain gene in co-operation with 
the promotor. Enhancer sequences can be located upstream or downstraam of the gene or within 
the gene. The distance between the enhancer and the gene under the influence of this en ha neer, can 
be considerable. 
Expression product: a specific protein, polypeptide or RNA molecule, coded for by the DNA sequènce 
of a gene. 
Gene: specific DNA sequence, usually coding for a protein that accomplishes a specific tunetion 
within the organism. 
Genetic construct: DNA sequence of a genetic element obtained by applying recombinant-DNA 
techniques. 
Genetic modification: addition, deletion, substitution or other farms of modification of the genetic 
material of an organism by the application of new techniques, especially recombinant-DNA and cell 
fusion techniques in a way that would not be possible by natural reproduetion or recombination. 
Genome: total of genetic material in a cell. 
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GLP (Good Labaratory Practice): the organisational process and the conditions under which 
Iabaratory studies are planned, performed, monitored, recorded and reported. 
GMP (Good Manufacturing Practice): the organisational process and the conditions under which 
products are produced and processed in order to prevent the formation of unintended by-products, 
and to avoid contamination, mixing or wrong labelling. 
GRAS ( Generally Regarded As Safe): mark that is given to products or substances that have a long 
tradition of safe use without being explicitly tested toxicologically. 
Homologous recombination: process of DNA-exchange in which sequences in the host genome are 
replaced by partly identical sequences. 
lmmunotoxicity: harmful effects of taxie substances to the immunological defence system. 
lnsertional mutagenesis: mutagenesis resulting from the incorporation of a new DNA sequence. 
Marker gene: gene with a recognisable or selectable phenotype which, tor this reason, is included 
in a genetic construct. After the transformation experiment expression of the marker gene will show 
whether or nat the transformation was successful. 
mRNA (messenger ribonucleic acid) : farm of RNA, transcribed trom the DNA, that provides ribasomes 
with the necessary information tor the synthesis of a protein. 
Mutagenesis: process resulting in the modification of a DNA sequence. 
Natural toxin: taxie substance in agricultural food productsas a result of biosynthesis in the organism 
or as a result of natural prevalenee in the environment. 
Pleiotropie effects: unintended side-effects as a result of a change in the genetic material of an 
organism. 
Promotor: 
DNA sequence located upstream of a gene and regulating the expression of this gene. The distance 
between the promotor and the gene is usually rather constant. 
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Protocol toxicological research: research to investigate possible harmful effects of substances 
according to specific research guidelines. 
Protoplast: plant cell after remaval of the cell wall. 
Aecombinant-DNA techniques: set of techniques to selectively cut and recombine DNA sequences 
in order to change the genetic material of an organism in a specific way. 
Regulator element: DNA sequence that influences the expression of a gene, for example a promotor 
or enhancer. 
Secondary effects: indirect effects of the expression of a gene on the metabolism of the host 
organism. 
Sensibilisation: increased sensitivity to a substance as a result of an immunological reaction on 
repeated exposure. 
Somaclonal variation: phenotypic expression of genetic changes that can be observed atter cell or 
tissue culture procedures. 
Transformation: process to incorporate foreign DNA sequences permanently into the genome of a 
cell. 
Transgenesis: process of genetic modification incorporating a foreign gene into the host genome. 
Transposon: DNA segment with the ability to jump within the genome. Under specific conditions 
transposition can also take place trom one genome to another. 
Vector: DNA segment used to introduce foreign DNA into the host genome in order to express new 
genes or to amplify the incorporated gene. 
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